Literature DB >> 16771952

Mucosal barrier defects in irritable bowel syndrome. Who left the door open?

Giovanni Barbara.   

Abstract

There has been recent interest into the potential role of cellular and molecular mechanisms in the pathophysiology of irritable bowel syndrome (IBS). Although the intestinal mucosa of IBS patients is endoscopically and histologically "normal," it contains an increased number of activated T lymphocytes and mast cells, along with evidence of an increased release of mediators known to signal to epithelial, neuronal, and muscle cells leading to intestinal dysfunction. In this issue, Dunlop et al. provide evidence of increased intestinal permeability in patients with diarrhea predominant IBS. There is now consistent evidence indicating that mucosal barrier defects allow the passage of an increased load of luminal antigens of dietary and bacterial origin which, in turn, elicit the activation of mucosal immune responses involved in the generation of diarrhea. Further work has now to be done to better understand the interplay among luminal factors, epithelial cells, and mucosal immunocytes in the pathogenesis of IBS.

Entities:  

Mesh:

Year:  2006        PMID: 16771952     DOI: 10.1111/j.1572-0241.2006.00667.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  36 in total

1.  Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study.

Authors:  A Y Del Valle-Pinero; A C Martino; T J Taylor; B L Majors; N S Patel; M M Heitkemper; W A Henderson
Journal:  Neurogastroenterol Motil       Date:  2011-09-23       Impact factor: 3.598

2.  Response to Marasco et al.

Authors:  Pirjo Wacklin; Pilvi Laurikka; Katri Lindfors; Jaana Mättö; Kalle Kurppa; Katri Kaukinen
Journal:  Am J Gastroenterol       Date:  2015-04       Impact factor: 10.864

3.  Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients?

Authors:  Giovanni Marasco; Antonio Colecchia; Davide Festi
Journal:  Am J Gastroenterol       Date:  2015-04       Impact factor: 10.864

Review 4.  Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome.

Authors:  Pejman Katiraei; Gilberto Bultron
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

5.  PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity.

Authors:  T A Nelson; S Holmes; A V Alekseyenko; M Shenoy; T Desantis; C H Wu; G L Andersen; J Winston; J Sonnenburg; P J Pasricha; A Spormann
Journal:  Neurogastroenterol Motil       Date:  2010-12-03       Impact factor: 3.598

Review 6.  Irritable bowel syndrome: a clinical review.

Authors:  Rosa L S Soares
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

7.  The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology.

Authors:  Tara J Taylor; Nader N Youssef; Ravi Shankar; David E Kleiner; Wendy A Henderson
Journal:  BMC Res Notes       Date:  2010-10-21

8.  Importance of neural mechanisms in colonic mucosal and muscular dysfunction in adult rats following neonatal colonic irritation.

Authors:  A Chaloner; A Rao; E D Al-Chaer; B Greenwood-Van Meerveld
Journal:  Int J Dev Neurosci       Date:  2009-09-17       Impact factor: 2.457

9.  Early weaning stress impairs development of mucosal barrier function in the porcine intestine.

Authors:  Feli Smith; Jessica E Clark; Beth L Overman; Christena C Tozel; Jennifer H Huang; Jean E F Rivier; Anthony T Blikslager; Adam J Moeser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-19       Impact factor: 4.052

10.  Stress and gene expression of individuals with chronic abdominal pain.

Authors:  Ralph Michael Peace; Benjamin L Majors; Nayan S Patel; Dan Wang; Arseima Y Del Valle-Pinero; Angela C Martino; Wendy A Henderson
Journal:  Biol Res Nurs       Date:  2012-10       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.